Table 1.
Study | Psychopathology | Design | N | Age | Conditions | ER measure | Quality rating |
---|---|---|---|---|---|---|---|
Slee et al. (2008)—The Netherlands | BPD | RCT | 82 | 24.2 | CBT − TAU | DERS | Strong |
Schuppert et al. (2012)—The Netherlands | BPD | RCT | 109 | 15.98 | ERT − TAU | LPI subscale—emotion dysregulation | Strong |
Suveg et al. (2017)—USA | AD | RCT | 92 | 8.93 | ECBT − CBT | ERC | Moderate |
Dingle et al. (2017)—Australia | AD, MD | RCT | 51 | 18.68 | ERP − WL | DERS | Moderate |
Hides et al. (2011)—Australia | MD, SUB | RCT | 88 | 19.2 | CBT + MI – TAU | CISS | Weak |
Atkinson et al. (2016)—Australia | ED | RCT | 33 | 20.57 |
MF − WL Dissociationa |
FFMQ | Weak |
Azrin et al. (2001)—USA | CD, SUB | RCT | 56 | 15.4 | CPS − FBT | SPSI-R | Moderate |
Stasiak et al. (2014)—New Zealand | MD | RCT (pilot) | 34 | 15.2 | cCBT − TAU | ACS-PS | Moderate |
Jacobs et al. (2016) | MD | RCT | 33 | 15.5 | RCBT − WL | RRS | Strong |
Livheim et al. (2015)—Australia | MD | QRCT | 51 | 14.6 | ACT − TAU | AFQ | Strong |
1Livheim et al. (2015)—Sweden | MD | RCT | 32 | 14.5 | ACT − TAU | AFQ, MAAS | Weak |
Kaufman et al. (2005)—USA | MD, CD | RCT | 93 | 15.1 | CBT − LS | IC-PS | Strong |
Hennesdottir et al. (2017)—Iceland | ADHD | RCT (pilot) | 30 | 9.2 |
CBT − WL Parent traininga |
ERC | Strong |
Meisner-Stedman et al. (2017) | AD | RCT | 29 | 24.56 | CTPTSD − WL | Rumination items | Strong |
1Essau et al. (2012)—Germany | AD | CRCT | 638 | 10.91 | CBT − WL | CSCY-PS | Moderate |
Latimer et al. (2003)—USA | SUB | RCT (pilot) | 43 | 16.07 | CBT − DHPE | SPSI | Moderate |
Winters et al. (2012) | SUB | QRCT | 192 | 16.13 |
MI-A − WL MI-Pa |
PSQ | Moderate |
Smith et al. (2015) | MD | RCT | 109 | 13–16 | cCBT − WL | CRSQ | Strong |
Fitzpatrick et al. (2005)—USA | MD | RCT | 94 | 19.02 | PS − Health Education | SPSI-R | Moderate |
Multi-treatment trials entered with split groups | |||||||
Hancock et al. (2016)—Australia | AD | RCT | 99 | 13.8 | ACT − WL | AFQ | Strong |
AD | RCT | 94 | 13.8 | CBT − WL | AFQ | Strong | |
Afshari et al. (2014)—Iran | AD | RCT | 77 | 10.57 | ERT− WL | CERQ, CEMS | Weak |
AD | RCT | 55 | 10.57 | CBT− WL | CERQ, CEMS | Weak |
BPD borderline personality disorder, AD anxiety disorder, MD major depression, SUB substance abuse, ED eating disorder, CD conduct disorder, ADHD attention deficit hyperactivity disorder, RCT randomized control trial, QRCT quasi-randomized control trial, CBT cognitive behavioural therapy, TAU treatment as usual, ERT emotion regulation training, ECBT emotion-focussed CBT, ERP emotion regulation program, WL waitlist, MI motivational interviewing, MF mindfulness, CPS cognitive problem solving, FBT family behavioural therapy, cCBT computerized CBT, RCBT rumination focussed CBT, ACT acceptance and commitment therapy, LS life skills, CT-PTSD cognitive therapy for PTSD, DGPE drugs harm psychoeducation curriculum, MIA motivation interviewing adolescence, MI-P motivation interviewing parents, PS problem solving, DERS difficulties with emotion regulation scale, LPI life problems inventory, ERC emotion regulation checklist, CISS coping inventory for stressful situations, FFMQ five factor mindfulness questionnaire, SPSI-R social problem solving inventory-revised, ACS-PS adolescent coping scale-problem solving, RRS ruminative response scale, AFQ avoidance and fusion questionnaire, MAAS mindful attention awareness scale, IC-PS issues checklist-problem solving, CSCY coping scale for children and youth, PSQ problem solving questionnaire, CRSQ child response style questionnaire, CERQ cognitive emotion regulation questionnaire, CEMS children’s emotion management scale
aCondition was part of multi-treatment trial and was excluded from meta-analysis 1outlier study removed from main analysis